The interaction mechanism between autophagy and apoptosis in colon cancer

Qingqiang Xie1, Yuan Liu1, Xuefeng Li2

  • 1The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital; State Key Laboratory of Respiratory Disease, Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, PR China.

Translational Oncology
|September 20, 2020
PubMed

Insights

Autophagy and apoptosis interact in cancer, influencing treatment outcomes. Understanding this relationship is key to overcoming drug resistance in colorectal cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Pathways

Background:

  • Autophagy and apoptosis are critical in tumorigenesis, with complex interactions impacting anti-tumor therapy.
  • Apoptosis is a primary mechanism for tumor cell death, while autophagy can be either protective or lethal.
  • Colorectal cancer (CRC) presents a significant health burden, and acquired drug resistance limits treatment efficacy.

Purpose of the Study:

  • To review the intricate relationship between autophagy and apoptosis in colorectal cancer.
  • To elucidate how this interplay influences drug resistance in colon cancer.
  • To highlight factors involved in the autophagy-apoptosis axis for improved therapeutic strategies.

Main Methods:

  • Literature review focusing on studies investigating autophagy and apoptosis in cancer.
  • Analysis of research on the dual role of autophagy (protective vs. lethal).
  • Examination of molecular mechanisms underlying drug resistance in colorectal carcinoma.

Main Results:

  • Autophagy exhibits dual roles in cancer: protective autophagy can hinder drug-induced apoptosis, while lethal autophagy can promote it.
  • Autophagy is identified as a major contributor to drug resistance in colon cancer.
  • The synergistic and antagonistic effects of autophagy and apoptosis are crucial in tumor progression and treatment response.

Conclusions:

  • Elucidating the autophagy-apoptosis cross-talk is essential for overcoming drug resistance in colorectal cancer.
  • Targeting the autophagy-apoptosis pathway holds promise for enhancing the efficacy of anticancer drugs.
  • Further research into related factors can lead to improved clinical strategies for colorectal cancer treatment.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.0K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.8K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.5K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
13.3K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.5K